Changes in cytokines, biomarkers of bone turnover and hormones are: Associated with bone loss in postmenopausal Indian women

International Journal of Endocrinology and Metabolism

Volumn 10, Issue 1, 2012, Pages 399-403

  Desai, Meena ^a   Khatkhatay, Mohammed Ikram ^a   Taskar, Vijaya ^b   Ansari, Zakiya ^a  

^a UNIVERSITY OF MUMBAI   (India)

^b Streehitakarini Clinic   (India)

Author keywords

Cytokines; Estrogens; Postmenopausal osteoporosis

Indexed keywords

ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; DEOXYPYRIDINOLINE; ESTRONE; FOLLITROPIN; GLUCURONIDE; INTERLEUKIN 1BETA; INTERLEUKIN 6; OSTEOCALCIN; PARATHYROID HORMONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BONE DENSITY; BONE TURNOVER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMUR; HUMAN; INDIAN; MAJOR CLINICAL STUDY; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; POSTMENOPAUSE; PREMENOPAUSE; SPINE; URINALYSIS; WOMEN'S HEALTH;

EID: 84864019195     PISSN: 1726913X     EISSN: 17269148     Source Type: Journal    
DOI: 10.5812/ijem.3339     Document Type: Article

References (30)

1. Cioffi M, Esposito K, Vietri MT, Gazzerro P, D'Auria A, Ardovino I, et al. Cytokine pattern in postmenopause. Maturitas. 2002;41 (3):187-92.
2. Kamada M, Irahara M, Maegawa M, Ohmoto Y, Takeji T, Yasui T, et al. Postmenopausal changes in serum cytokine levels and hormone replacement therapy. Am J Obstet Gynecol. 2001;184 (3):309-14.
3. Kumru S, Godekmerdan A, Yilmaz B. Immune effects of surgical menopause and estrogen replacement therapy in peri-menopausal women. J Reprod Immunol. 2004;63 (1):31-8.
4. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science. 1992;257 (5066):88-91.
5. Pacifici R. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res. 1996;11 (8):1043-51.
6. Prince RL. Counterpoint: estrogen effects on calcitropic hormones and calcium homeostasis. Endocr Rev. 1994;15 (3):301-9.
7. Lorentz K. Improved determination of serum calcium with 2-cresolphthalein complexone. Clin Chim Acta. 1982;126 (3):327-34.
8. Gomorri GA. Modification of calorimetric phosphorous determination for use with photoelectric calorimeter. J lab Clin Med. 1942;27:955-60.
9. Desai M, Khatkhatay I, Sankolli G, Meherji P, Joshi U. Enzyme-labelled immunoassay for urinary gonadotropins using penicillinase. Clin Chim Acta. 1989;184 (3):315-21.
10. Khatkhatay MI, Sankolli GM, Meherji PK, Chowdhury V, Joshi UM. Excretion of estrone-3-glucuronide in urine in spontaneous and induced ovulatory cycles. Int J Fertil. 1988;33 (3):181-7.
11. Jaffe M. Uberden Niederschlag Welchen Pickrinasure in normalem Harn erzengl and uberein nene Reaklion des Kreatinine Z. Physiol Chem. 1886;10:391-4.
12. WHO. Technical Reports Series 843 Assessment of fracture risk and its application to screening for postmenopausal osteoporosis Geneva; 1994 [updated 1994; cited]; Available from: http:// www.who.int/entity/chp/topics/Osteoporosis.pdf.
13. Desai Meena P, Khatkhatay MI, Bhanu Prakash KV, Savardekar LS, Shah RS, Ansari Z. Hormonal profiles and biochemical indices of bone turnover in Indian women. Osteoporos Int. 2007;18 (7):923-9.
14. Desai MP, Bhanuprakash KV, Khatkhatay MI, Donde UM. Age-related changes in bone turnover markers and ovarian hormones in premenopausal and postmenopausal Indian women. J Clin Lab Anal. 2007;21 (2):55-60.
15. Romas E, Martin TJ. Cytokines in the pathogenesis of osteoporosis. Osteoporos Int. 1997;7 (Suppl 3):S47-53.
16. Berg G, Ekerfelt C, Hammar M, Lindgren R, Matthiesen L, Ernerudh J. Cytokine changes in postmenopausal women treated with estrogens: a placebo-controlled study. Am J Reprod Immunol. 2002;48 (2):63-9.
17. Horwood NJ, Udagawa N, Elliott J, Grail D, Okamura H, Kurimoto M, et al. Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor. J Clin Invest. 1998;101 (3):595-603.
18. de Bont N, Netea MG, Rovers C, Smilde T, Demacker PN, van der Meer JW, et al. LPS-induced cytokine production and expression of LPS-receptors by peripheral blood mononuclear cells of patients with familial hypercholesterolemia and the effect of HMG-CoA reductase inhibitors. Atherosclerosis. 1998;139 (1):147-52.
19. Barks JL, McQuillan JJ, Iademarco MF. TNF-alpha and IL-4 synergistically increase vascular cell adhesion molecule-1 expression in cultured vascular smooth muscle cells. J Immunol. 1997;159 (9):4532-8.
20. Fagiolo U, Cossarizza A, Scala E, Fanales-Belasio E, Ortolani C, Cozzi E, et al. Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol. 1993;23 (9):2375-8.
21. Khosla S, Peterson JM, Egan K, Jones JD, Riggs BL. Circulating cytokine levels in osteoporotic and normal women. J Clin Endocrinol Metab. 1994;79 (3):707-11.
22. Daynes RA, Araneo BA, Ershler WB, Maloney C, Li GZ, Ryu SY. Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative. J Immunol. 1993;150 (12):5219-30.
23. Papadopoulos NG, Georganas K, Skoutellas V, Konstantellos E, Lyritis GP. Correlation of interleukin-6 serum levels with bone density in postmenopausal women. Clin Rheumatol. 1997;16 (2):162-5.
24. Kania DM, Binkley N, Checovich M, Havighurst T, Schilling M, Ershler WB. Elevated plasma levels of interleukin-6 in postmenopausal women do not correlate with bone density. J Am Geriatr Soc. 1995;43 (3):236-9.
25. Pacifici R, Brown C, Puscheck E, Friedrich E, Slatopolsky E, Maggio D, et al. Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc Natl Acad Sci U S A. 1991;88 (12):5134-8.
26. Yasui T, Maegawa M, Tomita J, Miyatani Y, Yamada M, Uemura H, et al. Changes in serum cytokine concentrations during the menopausal transition. Maturitas. 2007;56 (4):396-403.
27. Scheidt-Nave CE, Bismar H, G. L-B, Seibel MJ, Ziegler R, Pfeilschifter J. Serum interleukin-6 is a major predictor of bone loss in women specific to the first decade past menopause. 1997 (Suppl 147).
28. Abrahamsen B, Bonnevie-Nielsen V, Ebbesen EN, Gram J, Beck-Nielsen H. Cytokines and bone loss in a 5-year longitudinal study--hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist: the Danish Osteoporosis Prevention Study. J Bone Miner Res. 2000;15 (8):1545-54.
29. Ershler WB. Interleukin-6: a cytokine for gerontologists. J Am Geriatr Soc. 1993;41 (2):176-81.
30. Lutgendorf SK, Garand L, Buckwalter KC, Reimer TT, Hong SY, Lubaroff DM. Life stress, mood disturbance, and elevated interleukin-6 in healthy older women. J Gerontol A Biol Sci Med Sci. 1999;54 (9):M434-9.